| Period Ending | Dec 28, 2012 | Sep 28, 2012 | Jun 29, 2012 | Mar 30, 2012 |
|---|
|
Total Revenue
|
5,963
|
6,391
|
10,552
|
13,967
| | Cost of Revenue | 5,126 | 6,003 | 7,814 | 8,531 | | |
Gross Profit
|
837
|
388
|
2,738
|
5,436
| |
|
Operating Expenses |
|
Research Development | 2,618 | 2,615 | 3,770 | 3,842 |
|
Selling General and Administrative | 2,098 | 2,497 | 2,871 | 2,609 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
(3,879)
|
(4,724)
|
(3,903)
|
(1,015)
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (146) | 4 | 3 | 5 |
|
Earnings Before Interest And Taxes | (4,025) | (4,720) | (3,900) | (1,010) |
|
Interest Expense | 90 | 98 | 79 | 71 |
|
Income Before Tax | (4,115) | (4,818) | (3,979) | (1,081) |
|
Income Tax Expense | (17) | 4 | 1 |
-
|
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | (4,098) | (4,822) | (3,980) | (1,081) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
(4,098)
|
(4,822)
|
(3,980)
|
(1,081)
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
(4,098)
|
(4,822)
|
(3,980)
|
(1,081)
|
|
0.02(2.74%) 9:33AM EDT - Nasdaq Real Time Price